Wuxi AppTec Co (STU:WX8) Cyclically Adjusted Revenue per Share: €1.35 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:WX8 Wuxi AppTec Co Ltd STU:WX8
91 GF Score
Price €21.34
GF Value €13.64
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Wuxi AppTec Co Cyclically Adjusted Revenue per Share?

Wuxi AppTec Co STU:WX8 +10.02% 91 Cyclically Adjusted Revenue per Share is €1.35 as of Jun. 2026. GuruFocus rates STU:WX8 with a GF Score™ of 91/100 and a GF Value™ of €13.64 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Wuxi AppTec Co's adjusted revenue per share for the three months ended in Jun. 2026 was €0.715. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.35 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-09), Wuxi AppTec Co's current stock price is €21.335. Wuxi AppTec Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €1.35. Wuxi AppTec Co's Cyclically Adjusted PS Ratio of today is 15.80.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Wuxi AppTec Co was 15.81. The lowest was 10.20. And the median was 10.85.


Wuxi AppTec Co  (STU:WX8) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Wuxi AppTec Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=21.335/1.35
=15.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Wuxi AppTec Co was 15.81. The lowest was 10.20. And the median was 10.85.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Wuxi AppTec Co Cyclically Adjusted Revenue per Share Related Terms


Wuxi AppTec Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Wuxi AppTec Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wuxi AppTec Co Cyclically Adjusted Revenue per Share Chart

Wuxi AppTec Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Wuxi AppTec Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1.25 1.35

STU:WX8 vs TMO, DHR, IDXX: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Wuxi AppTec Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's Cyclically Adjusted PS Ratio falls into.


STU:WX8
91GF Score
Wuxi AppTec Co Ltd STU:WX8
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wuxi AppTec Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Wuxi AppTec Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.715/116.0564*116.0564
=0.715

Current CPI (Jun. 2026) = 116.0564.

Wuxi AppTec Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 0.000 100.600 0.000
201612 0.000 102.600 0.000
201703 0.109 103.200 0.123
201706 0.112 103.100 0.126
201709 0.112 104.100 0.125
201712 0.123 104.500 0.137
201803 0.125 105.300 0.138
201806 0.126 104.900 0.139
201809 0.128 106.600 0.139
201812 0.134 106.500 0.146
201903 0.135 107.700 0.145
201906 0.143 107.700 0.154
201909 0.152 109.800 0.161
201912 0.167 111.200 0.174
202003 0.147 112.300 0.152
202006 0.185 110.400 0.194
202009 0.205 111.700 0.213
202012 0.203 111.500 0.211
202103 0.217 112.662 0.224
202106 0.246 111.769 0.255
202109 0.267 112.215 0.276
202112 0.300 113.108 0.308
202203 0.391 114.335 0.397
202206 0.414 114.558 0.419
202209 0.456 115.339 0.459
202212 0.507 115.116 0.511
202303 0.403 115.116 0.406
202306 0.434 114.558 0.440
202309 0.466 115.339 0.469
202312 0.465 114.781 0.470
202403 0.347 115.227 0.349
202406 0.408 114.781 0.413
202409 0.459 115.785 0.460
202412 0.532 114.893 0.537
202503 0.429 115.116 0.433
202506 0.471 114.907 0.476
202509 0.501 115.471 0.504
202512 0.512 115.832 0.513
202603 0.530 116.303 0.529
202606 0.715 116.056 0.715

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €1.35 mean?
Wuxi AppTec Co (STU:WX8) has a Cyclically Adjusted Revenue per Share of €1.35 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Wuxi AppTec Co and its competitors.
Is Wuxi AppTec Co's Cyclically Adjusted Revenue per Share too high?
Wuxi AppTec Co's current Cyclically Adjusted Revenue per Share is €1.35. Overall, Wuxi AppTec Co has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's Cyclically Adjusted Revenue per Share compare to TMO and DHR?
Wuxi AppTec Co's Cyclically Adjusted Revenue per Share of €1.35 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Wuxi AppTec Co and its competitors. Wuxi AppTec Co's current Cyclically Adjusted Revenue per Share is €1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (STU:WX8) is currently considered Significantly Overvalued. The stock's GF Value™ is €13.64, compared to a current price of €21.34 — trading 56.4% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €1.35. Wuxi AppTec Co's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Wuxi AppTec Co (STU:WX8), the current Cyclically Adjusted Revenue per Share is €1.35 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wuxi AppTec Co (STU:WX8) Overvalued in 2026?

Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued. The current stock price of €21.34 is trading 56.4% above its estimated GF Value™ of €13.64. GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.

Key valuation signals for STU:WX8:

  • Cyclically Adjusted Revenue per Share: €1.35
  • GF Value™: €13.64 vs. price of €21.34 (56.4% above fair value)
  • GF Score™: 91/100 with 6 warning signs

No single metric tells the full story. See the STU:WX8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Wuxi AppTec Co Business Description

Address 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
91GF Score

Get the complete analysis for STU:WX8

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.34
Price
€13.64
GF Value